Showing 1 - 10 of 626
Recent work linking the adoption of key organizational practices to productivity raises an important question: if adoption increases productivity so dramatically, why does adoption across an industry take so long? This paper explores this question in the context of one particularly interesting...
Persistent link: https://www.econbiz.de/10013216492
international patent applications in the US, Japan, the European Patent Office, and corresponding filings in three developing …
Persistent link: https://www.econbiz.de/10012964387
Using Japanese firm-level data for the period from 1994-2002, this paper examines whether a firm is chosen as an acquisition target based on its productivity level, profitability and other characteristics and whether the performance of Japanese firms that were acquired by foreign firms improves...
Persistent link: https://www.econbiz.de/10012760742
We explore how changes in ownership and managerial control affect the productivity and profitability of producers. Using detailed operational, financial, and ownership data from the Japanese cotton spinning industry at the turn of the last century, we find a more nuanced picture than the...
Persistent link: https://www.econbiz.de/10013058693
existing firms or -- much more frequently -- exploited by new entrants in the U.S. In Japan this new dominant technology has … organizational change is necessary for incumbent firms to remain competitive and, ultimately, to survive. Japan's sharply higher … organizational change/new entry ratio compared to the U.S. during the biotech revolution is related to Japan's relatively compact …
Persistent link: https://www.econbiz.de/10013232001
Using a unique dataset on all major corporate restructuring events in Japan between 1981 and 2010, we examine how bank …-led rescue operations in Japan have changed over time. The incidence of restructuring by distressed firms has become less … findings as strong indicators of changing corporate governance in Japan, in particular in terms of the decline in corporate …
Persistent link: https://www.econbiz.de/10012949406
We empirically analyze the welfare effects of cross-firm bundling in the pharmaceutical industry. Physicians often treat patients with "cocktail" regimens that combine two or more drugs. Firms cannot price discriminate because each drug is produced by a different firm and a physician creates the...
Persistent link: https://www.econbiz.de/10013138761
In this survey chapter on pricing and reimbursement in U.S. pharmaceutical markets, we first provide background information on important federal legislation, institutional details regarding distribution channel logistics, definitions of alternative price measures, related historical...
Persistent link: https://www.econbiz.de/10013139118
This paper explores price differences in the European Union (EU) pharmaceutical market, the EU's fifth largest industry. With the aim of enhancing quality of life along with industry competitiveness and R&D capability, many EU directives have been adopted to achieve a single EU-wide...
Persistent link: https://www.econbiz.de/10013139285
The recent reform of the U.S. health care system has been described both as a boon and a death blow for the healthcare industry and for private insurers in particular. We exploit the surprise election of Republican Scott Brown to the U.S. Senate, which dealt a serious blow to the prospects for...
Persistent link: https://www.econbiz.de/10013140997